Keywords: actelion, posts, 1st-half, sales, growth, switzerland-based, posted
Actelion posts 1st-half sales growth of 63%
Article | 02 August 2004
Switzerland-based Actelion has posted total net revenues of 215.0million Swiss francs ($170.2 million) for the first half of 2004, marking a 63% increase ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
